← Eichor
Study identifier: NCT04144907 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Protein Needs Study

Condition: Colorectal Cancer · Breast Cancer  ·  Sponsor: University of Alberta

PhaseNA
Planned participants40
Who can joinAll sexes, 45 Years to 80 Years
Healthy volunteersNo

About this study

Severe muscle loss in patients with cancer has been associated with increased physical disability, extended hospitalization, infectious and noninfectious complications, increased risk of severe toxicity during cancer treatment, poor quality of life and shortened survival. Adequate protein is key to sustain muscle mass and overall health. However, current nutritional recommendations are not specific or evidence-based. The aim of this project is to determine the protein needs of patients with colorectal or breast cancer. Protein needs will be determined using a novel, non-invasive approach. Our results will inform nutritional recommendations and guidelines with the ultimate goal of improving outcomes for people with cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Anne Caretero, RD  ·  780-492-7820  ·  caretero@ualberta.ca

Always discuss trial participation with your own doctor first.

Locations (1)

University of AlbertaEdmonton, Alberta, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04144907